The Importance of Subgroup Analysis in Drug-Eluting Stent Trials
- 1 January 2016
- journal article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 9 (1) , 39-41
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsJACC: Cardiovascular Interventions, 2016
- Prevalence and Impact of High Platelet Reactivity in Chronic Kidney DiseaseCirculation: Cardiovascular Interventions, 2015
- Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in OntarioCirculation: Cardiovascular Interventions, 2015
- TCT-362 Relation between renal function and neointimal tissue characteristics after drug-eluting stent implantation: virtual histology-intravascular ultrasound analysisJACC, 2014
- High Clopidogrel Dose in Patients With Chronic Kidney Disease Having Clopidogrel Resistance After Percutaneous Coronary InterventionAngiology, 2014
- Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) StudyCirculation, 2014
- Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney DiseaseAnnals of Internal Medicine, 2012
- Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary InterventionThe American Journal of Cardiology, 2009
- Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass SurgeryCirculation, 2006